Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Alnylam Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- eHealth, Inc. Q3 2008 Earnings Call Transcript
- MIPS Technologies, Inc. F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- Alkermes, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Akorn, Inc. Q3 2008 Earnings Call Transcript
- Energy XXI (Bermuda) Limited F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- The Advisory Board Company F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Thomas Weisel Partners Group, Inc. Q3 2008 Earnings Call Transcript
- The9 Q3 2008 Earnings Call Transcript
-
Editors' Picks
-
Most Popular
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Key to the Global Equity Market: Trend and Cycle Analysis of U.S. Retail
- Can a Global Economy Be Managed One Nation at a Time?
- Global Markets Week in Review: Turbulent Times
- Full list of Editors' Picks »
- Jim Rogers on China »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- Peak Oil's Bell Is Ringing »
- UltraShort ETFs: At a Tipping Point? »
- The Biggest Problem Detroit's Big Three Face »
- 11 Stocks Selling Below Cash »
- Tech May Be a Wreck, But This Isn't 2001 »
- The Autos and Mentality That Ruined Detroit »
- Iceland: What It's Like to Live in a World Without Money »
- Wall Street Breakfast: Must-Know News »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Tibcomonkey
3 Comments
Correction and Clarification to Tysabri Post
Thanks for correcting the Remicade error. I'm curious about something else though. Other responders to your article made it clear that there are has never been a case of PML with Tysabri in a monotherapy setting. This is the only way that Tysabri can be administered. Therefore there are no links as such to PML in the way that Tysabri is currently being administered. The links are to Tysabti/Avonex and to Tysabry/Azathioprine combination usage and we do not know, in these cases even if Tysabri was a causative agent. Why is so difficult for writers, such as yourself to simply write that there has, to date, in over 20,000 patients, never been a case of PML in Tysabri monotherapy. Surely the MS patients currently taking the medication deserve to know this simple fact instead of being scared by partially false and misleading information?
Sun-MySQL: The Real Winner is Oracle
I'm curious where SUN has or will compete with SAP. To move to the business applications level, SUN's only option is to partner with both Oracle and SAP. The odds of them finding or building a competitive ERP suite are exactly zero.
Elan, Biogen Idec Won't Gain Much from Tysabri Approval
I'm sure J&J will be very concerned to learn they have lost their valuable Remicade franchise to Schering-Plough's (SGP).
Perhaps a small amount of research prior to writing would not go amiss!